{{Rsnum
|rsid=2296147
|Gene=BIVM-ERCC5
|Chromosome=13
|position=102846025
|Orientation=plus
|GMAF=0.3035
|Gene_s=BIVM-ERCC5,ERCC5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.6 | 49.1 | 31.2
| HCB | 2.9 | 34.3 | 62.8
| JPT | 1.8 | 17.7 | 80.5
| YRI | 2.7 | 25.9 | 71.4
| ASW | 7.0 | 36.8 | 56.1
| CHB | 2.9 | 34.3 | 62.8
| CHD | 4.6 | 36.7 | 58.7
| GIH | 12.9 | 57.4 | 29.7
| LWK | 2.7 | 24.5 | 72.7
| MEX | 5.2 | 37.9 | 56.9
| MKK | 3.2 | 35.3 | 61.5
| TSI | 19.6 | 43.1 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=24353624
|Title=XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer
|OA=1
}}

{{PMID Auto
|PMID=20233728
|Title=Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.
|OA=1
}}

{{PMID Auto
|PMID=22371296
|Title=Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations.
}}

{{PMID Auto
|PMID=22982416
|Title=Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese.
}}

{{PMID Auto
|PMID=23211354
|Title=Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}